This inventor holds 65 USPTO granted patents and 2 published patent applications, plus 11 CIPO patents and 3 EPO patents, primarily in Heterocyclic Compounds (CPC class 5143). Top assignees: Neurogen Corporation, Merrell Pharmaceuticals, Inc., Novartis International Pharmaceutical, Ltd.. Active years: 1994-2014.
Inventors with similar research interests:
Location History:
- Cincinnati, OH (US) (1994 - 1999)
- Westbrook, CT (US) (1999 - 2001)
- Clinton, CT (US) (2000 - 2014)
Company Filing History:
36 out of 305 
10 out of 194 
6 out of 29 
Years Active: 1994-2014
Areas of Expertise:
Title: **George D. Maynard: A Pioneer in Pharmaceutical Innovation**
Introduction
George D. Maynard is an esteemed inventor based in Clinton, Connecticut. With an impressive portfolio of 65 patents, Maynard has made significant contributions to the field of pharmaceuticals, particularly in developing novel compounds for various medical applications. His innovative work focuses on addressing complex biological challenges through advanced chemical formulations.
Latest Patents
Maynard's latest patents include groundbreaking developments in pyrrolo-pyridine and pyrrolo-pyrimidine compounds. These heterocyclic compounds are designed to act as ligands for C5a receptors. Their high affinity binding properties, along with their potential to exhibit neutral antagonist or inverse agonist activity at these receptors, make them invaluable for treating numerous inflammatory, cardiovascular, and immune system disorders. Furthermore, his patent claims also extend to pharmaceutical compositions containing these compounds, as well as their applications as probes for C5a receptor localization.
Additionally, his patent concerning 3-aryl-5,6-disubstituted pyridazines reveals the potency of these compounds as modulators of metalloproteases, including matrix metalloproteases (MMPs) and ADAMs. These compositions hold promise for treating diseases linked to metalloprotease activity, such as arthritis, cancer, and various inflammatory or allergic conditions.
Career Highlights
Throughout his career, George D. Maynard has worked with prominent companies including Neurogen Corporation and Merrell Pharmaceuticals, Inc. His experiences at these organizations have undoubtedly played a crucial role in shaping his inventive pursuits and fostering collaborations that further his research initiatives.
Collaborations
In his endeavors, Maynard has collaborated with distinguished professionals such as Jun Yuan and Alan J. Hutchison. These collaborations reflect a commitment to advancing pharmaceutical science through teamwork and innovation, enhancing the development of breakthrough therapies.
Conclusion
George D. Maynard's contributions to pharmaceuticals are marked by a dedication to innovation and a profound understanding of medicinal chemistry. His extensive portfolio of patents demonstrates not only his inventive prowess but also his commitment to improving health outcomes through the development of novel therapeutic agents. As the field of pharmaceuticals continues to evolve, Maynard's work remains an essential part of the ongoing quest for effective treatments for a variety of medical conditions.